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Abstract 26 
 27 
In order to better define the role of male and female gonad-related factors (MGRF, 28 
presumably testosterone, and FGRF, presumably estradiol, respectively) on mouse hindlimb 29 
skeletal muscle contractile performance/function gain during postnatal development, we 30 
analysed the effect of castration initiated before puberty in male and female mice. We found 31 
that muscle absolute and specific (normalized to muscle weight) maximal forces 32 
weresdecreased in 6-month old male and female castrated mice, as compared to age- and 33 
sex-matched intact mice, without alteration in neuromuscular transmission. Moreover, 34 
castration decreased absolute and specific maximal powers, another important aspect of 35 
muscle performance, in 6-month old males, but not in females. Absolute maximal force was 36 
similarly reduced by castration in 3-month old muscle fibre androgen receptor (AR) -37 
deficient and wild-type male mice, indicating that the effect of MGRF was muscle fibre AR 38 
independent. Castration reduced the muscle weight gain in 3-month mice of both sexes and 39 
in 6-month females but not in males. We also found that bone morphogenetic protein 40 
signaling through Smad1/5/9 was not altered by castration in atrophic muscle of 3-month old 41 
mice of both sexes. Moreover, castration decreased the sexual dimorphism regarding muscle 42 
performance. Together these results demonstrated that in the long-term MGRF and FGRF 43 
promote muscle performance gain in mice during postnatal development, independently of 44 
muscle growth in males, largely via improving muscle contractile quality (force and power 45 
normalized) and that MGFR and FGRF also contribute to sexual dimorphism. However, the 46 
mechanisms underlying MGFR and FGRF actions remain to be determined. 47 
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Introduction 52 
 53 
The postnatal growth of skeletal muscle is due to muscle fibre hypertrophy (71) resulting 54 
from a high protein synthesis rate (19). After 1 month of age, the increase in fibre diameter 55 
in mice occurs without addition of myonuclei provided by satellite cells (71). Male gonad-56 
related factors (MGRF), in particular androgens (testosterone), are thought to play an 57 
important role in the postnatal development and maintenance of skeletal muscle mass, and 58 
sexual dimorphism of skeletal muscle. It is thought that the actions of androgens are mainly 59 
exerted through binding to the androgen receptor (AR), which directly modulates the 60 
transcription of target genes. In skeletal muscle, AR has been reported in satellite cells, 61 
muscle fibres and other cell lineages. Several animal studies reported that androgen 62 
deficiency resulting from castration of adult male animals causes variable levels of muscle 63 
atrophy (2, 9, 11, 30, 35, 37, 64), supporting the idea that MGRF play a role in the 64 
maintenance of muscle size. Less is known about the role of endogenous androgens, whose 65 
blood levels increase at puberty, on muscle contractile performance (function) gain during 66 
the postnatal development. Since muscle size is an important determinant of muscle 67 
performance, i.e. absolute maximal force and power, it is hypothesized that endogenous 68 
androgens contribute to the increase in muscle performance after puberty, but the target cells 69 
are unknown. Moreover, it remains largely unknown whether endogenous androgens affect 70 
specific maximal force and power (absolute maximal force or power/muscle weight) after 71 
puberty, i.e muscle contractile quality, another key determinant of muscle performance. 72 
 73 
Several recent studies concluded that female gonad-related factors (FGRF), in particular 74 
estrogens (estradiol), positively regulate absolute maximal force in adult female mice (7, 25, 75 
40, 41, 49). Three estrogen receptors, ERα, ERβ, and the G-protein coupled receptor (Gper), 76 
 5
have been identified in skeletal muscles.  Moreover, it was reported that some beneficial 77 
effects of estrogens on muscle contractility can be very rapid (within 30 min) in adult female 78 
mice, suggesting a non-genomic mechanism and that estrogens can affect muscle quality 79 
(40). However, the roles of FGRF on muscle performance gain during the postnatal 80 
development are not well established in female mice. Indeed, it has been reported that 81 
during postnatal development, estrogens decrease absolute maximal force (67) or have no 82 
effect in female rats (42). 83 
 84 
Despite recent developments, there is a tremendous lack of understanding of sex-based 85 
differences in muscle performance. Overall, evidence to date suggests that muscle 86 
performance is sex-dependent (15, 23, 27, 32–34, 62). Indeed, several studies reported that 87 
absolute maximal force and power are greater in adult male mice as compared to adult 88 
female mice (15, 33, 62), whilst others have not found such differences (23, 28). It is 89 
postulated that FGRF and MGRF contribute to the sexual dimorphism regarding muscle 90 
performance, however this remains to be firmly established. 91 
 92 
In order to further characterize the role of MGRF and FGRF on postnatal development of 93 
muscle contractile performance, i.e. absolute isometric maximal force and absolute maximal 94 
power derived from force-velocity relationship, we analyzed in adult male and female mice 95 
the effects of castration initiated before puberty. Absolute isometric maximal force and 96 
power derived from force-velocity relationship are two important aspects of muscle 97 
performance during locomotion and muscular exercise, ie. to accomplish work, althougth 98 
they overestimate the force and power output of a muscle during in vivo dynamic muscle 99 
contractions (36). Our general hypothesis was that MGRF and FGRF play important roles in 100 
performance gain in male and female mice respectively, between the age of 1 month and 6 101 
 6
months. We also tested the hypothesis that castration before puberty decreases sexual 102 
dimorphism regarding muscle performance in the adult stage. Moreover, we analyzed the 103 
effect of castration before puberty in the absence of muscle fibre AR in order to determine 104 
whether AR mediates the potential role of MGRF in this cell type. To address this objective, 105 
we used male mice with loss of muscle fibre AR (ARskm-/y mice) that were castrated before 106 
puberty or not. If it is the case, the effect of castration before puberty should be reduced in 107 
the absence of muscle fibre AR as compared with the presence of AR.  We also analysed the 108 
effect of castration on several key functional, cellular and molecular determinants of muscle 109 
contractile performance that include muscle contractile quality, i.e. specific maximal force 110 
and power, neuromuscular transmission, fibre atrophy, fibre type composition, fibrosis and 111 
remodeling pathways involved in muscle growth and physiology (such as bone 112 
morphogenetic protein signaling, ubiquitin ligases, MSTN, IGF-1). 113 
 114 
  115 
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Materials and Methods 116 
 117 
Mice 118 
 119 
All procedures were performed in accordance with European legislations, in conformity 120 
with the Public Health Service Policy on Humane Care and Use of Laboratory Animals, and 121 
were approved by the Comité d'éthique en expérimentation animale Charles Darwin #5 122 
(Ministère de l’Education Nationale, de l’Enseignement Supérieur et de la Recherche, 123 
France)(Autorisation de projet # 01361.03). Male and female wild type mice (C57BL/6 124 
background) were analyzed at the age of 1 month, 1.5 month, 3 months and 6 months. Body 125 
weights are shown in Table 1. Body weights were decreased in 3-month old male castrated 126 
mice and increased in 6-month old castrated female, as compared to age-and sex-matched 127 
intact mice (p < 0.05). Therefore, these results indicate no reduction in muscle demand 128 
during standing and locomotion at the age of 6 months. We also used muscle fibre AR 129 
deficient male mice (referred to below as ARskm-/y)(on a C57BL/6 background). ARskm-/y 130 
mice were generated by breeding female ARL2/L2 mice carrying “floxed” AR L2 alleles with 131 
male HSA-Cre transgenic mice, as described previously (9, 18). Sex matched wild-type 132 
littermates (ARL2/y mice) were used as controls. Male and female mice were castrated 133 
(ablation of gonads) at 1 month of age, before the onset of puberty (57).  134 
 135 
Muscle contractile performance 136 
 137 
Absolute isometric maximal force and power of the tibialis anterior (TA) muscle were 138 
evaluated by measuring the in situ muscle contractions in response to nerve stimulation, as 139 
described previously (22, 62, 69). Some plantaris muscles were also measured (18). Mice 140 
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were anesthetized using pentobarbital (60 mg/kg intraperitoneally). Body temperature was 141 
maintained at 37°C using radiant heat. The knee and foot were fixed with pins and clamps, 142 
and the distal tendon of the muscle was attached to a lever arm of a servomotor system 143 
(305B, Dual-Mode Lever, Aurora Scientific) using a non-elastic thread. The sciatic nerve 144 
was proximally crushed and distally stimulated by a bipolar silver electrode using 145 
supramaximal square wave pulses of 0.1 ms duration. Muscle was also directly stimulated 146 
after nerve stimulation at the frequency corresponding to maximal force in order to directly 147 
initiate muscle contraction in the case of neurotransmission failure (16). Stimulating 148 
electrodes were positioned on the midbelly of the muscle and the muscle was stimulated 149 
with a high strength voltage (80V). We measured the absolute maximal force that was 150 
generated during isometric contractions in response to electrical stimulation (frequency of 151 
75–150 Hz, train of stimulation of 500 ms). Absolute maximal force was determined at L0 152 
(length at which maximal tension was obtained during the tetanus). Absolute maximal force 153 
was normalized to the muscle mass as an estimate of specific maximal force, i.e. muscle 154 
contractile quality, a key determinant of muscle performance.  155 
 156 
Force-velocity data were then obtained by eliciting contractions in response to sciatic nerve 157 
stimulation (500 ms, 125 Hz) at 6 different afterloads (over a range of approximately 10-158 
50% absolute maximal force). The sciatic nerve was stimulated for 700 ms (125 Hz). A 159 
maximal isometric contraction of the muscle was initiated during the first 200 ms. Then, the 160 
muscle shortened during the last 300 ms against the load. Each contraction was separated by 161 
a 1 min rest period. The shortening velocity was measured during the first 20 ms of the 162 
shortening period. Absolute power was calculated (power = afterload x shortening velocity) 163 
and absolute maximal power was reported (mW). Specific maximal power (mW/g) was 164 
calculated by dividing maximal power by muscle weight, as another index of muscle 165 
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contractile quality and important determinant of muscle performance. After contractile 166 
measurements, the animals were sacrificed by cervical dislocation and muscles were 167 
dissected and weighed before being processed for downstream analyses.  168 
 169 
Neuromuscular junction morphology  170 
 171 
Neuromuscular junction (NMJ) analysis was performed on isolated muscle fibres as 172 
previously described (47, 59). Briefly, plantaris muscles were dissected and fixed in 173 
4%PFA/PBS for 30 min and rinsed with PBS at room temperature. Isolated muscle fibres 174 
were washed three times for 15 min in PBS, incubated for 30 min with 100 mM glycine in 175 
PBS and rinsed in PBS. Samples were permeabilized and blocked in blocking buffer (3% 176 
BSA/5% goat serum/0.5% Triton X-100 in PBS) for 4 hours at room temperature. They 177 
were then incubated overnight at 4°C with rabbit polyclonal antibodies against 68 kDa 178 
neurofilament (NF, Millipore Bioscience Research Reagents, 1:1000) and synaptophysin 179 
(Syn, Zymed, 1:200) in blocking buffer.  After four 1-hour washes in PBS, muscles were 180 
incubated overnight at 4°C with Cy3-conjugated goat anti-rabbit IgG (Jackson 181 
Immunoresearch Laboratories, 1:500) and Alexa Fluor 488-conjugated α-bungarotoxin (α -182 
BTX, Life Technologies, 1:1000) in blocking buffer. After four 1-hour washes in PBS, 183 
isolated muscle fibres were then flat-mounted in Vectashield (Vector Laboratories) 184 
mounting medium. Confocal images were acquired using Leica SPE confocal microscope 185 
with a Plan Apo 63x NA 1.4 oil objective (HCX; Leica). Confocal software (LAS AF; 186 
Leica) was used for acquisition of Z serial images, with a Plan Apo 63x NA 1.4 oil objective 187 
(HCX; Leica). Confocal images presented are single-projected image derived from image 188 
stacks. For all imaging, exposure settings were identical between compared samples and 189 
groups. Quantifications were done as previously (48), using ImageJ software (version 190 
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1.46m). AChR rich-endplate area per neuromuscular junction corresponds to the occupied 191 
area of α-BTX fluorescent signal. More than 20 fibres from at least five different mice of 192 
each group were analysed.  193 
 194 
Fibre size and type 195 
 196 
Transverse serial sections (8 µm) of TA muscles were obtained using a cryostat, in the mid-197 
belly region. Some of sections were processed for histological analysis according to standard 198 
protocols (stained for Sirius red). Others were used for immunohistochemistry as described 199 
(17, 38). For determination of muscle fibre diameter and myosin heavy chain (MHC) 200 
analysis, frozen unfixed sections were blocked 1h in PBS plus 2% BSA, 2% sheep serum. 201 
Sections were then incubated overnight with primary antibodies against laminin (rabbit 202 
polyclonal, 1:300, Dako, Les Ulis, France) and myosin heavy chain (MHC) isoforms 203 
(Developmental Studies Hybridoma bank, University of Iowa, USA). After washes in PBS, 204 
sections were incubated 1 h with secondary antibodies (alexa fluor, Life Technologies, Saint 205 
Aubin, France). For morphometric analyses images were captured using a motorized 206 
confocal laser-scanning microscope (LSM 700, Carl Zeiss SAS, Le Pecq, France). 207 
Morphometric analyses were made using ImageJ software and a homemade macro. The 208 
smallest diameter (min Ferret) of all the muscle fibres of the whole muscle section was 209 
measured. For muscle fibre diameter and fibre typing analyses all of the muscle fibres of the 210 
muscle section were measured. The extent of fibrosis was assessed by Sirius red staining. 211 
 212 
Remodeling pathways: protein 213 
 214 
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TA muscle was lysed in RIPA buffer [50 mM Tris pH 7.5, 1 % Nonident P40, 0.5 % 215 
Sodium Deoxycholate, 0.1 % SDS, 150 mM NaCl, 5 mM EDTA, 1 mM 216 
phenylmethanesulphonylfluoride (PMSF) and protease inhibitor cocktail (45 μg/mL, 11 873 217 
580 001, Roche)] with a potter at 4°C. Homogenates (100 μg of protein) were 218 
electrophoresed on 10 % polyacrylamid gels. Proteins were electroblotted to Hybond 219 
nitrocellulose membranes (Amersham Biosciences) and immunodetected using primary 220 
antibodies directed against Phospho-Smad1 (Ser463/465)/ Smad5 (Ser463/465)/ Smad9 221 
(Ser465/467) (#13820, Cell signaling, 1/1000), FoxO1 (#2880, cell signaling, 1/1000) 222 
Smad1/Smad9 (#ab108965, abcam, 1/1000), phospho-FoxO1 (Ser256) (#9461, cell 223 
signaling, 1/1000), FoxO3a (#12829, cell signaling, 1/1000), phospho-FoxO3a (Ser318/321) 224 
(#9465, cell signaling, 1/1000) and tubuline (IGBMC). Secondary antibodies conjugated to 225 
horseradish peroxidase (Amersham Biosciences) were detected using an enhanced 226 
chemiluminescence detection system (Pierce, Rockford, IL, 1/10000). 227 
 228 
 Remodeling pathways: mRNA 229 
 230 
Total RNA from the TA muscle was isolated using TRIzol Reagent (Invitrogen). A total of 2 231 
μg of RNA was reverse transcribed to cDNA with SuperScript II reverse transcriptase 232 
(Invitrogen Life Technologies) and random hexamer primers according to the supplier's 233 
protocol. Quantitative RT-PCR was performed by using the SYBR Green 1 marker PCR kit 234 
(Roche) according to the supplier's protocol (18). The 18S ribosomal RNA was used as an 235 
internal control. Primers were shown in Table 2. 236 
 237 
Statistical analysis 238 
 239 
 12
Groups were generally compared using 2 way-variance analysis (castration x age, sex x age, 240 
castration x genotype). If necessary, Bonferroni post-tests were also performed. For groups 241 
that did not pass tests of normality and equal variance, non-parametric tests were used 242 
(Kruskal Wallis and Wilcoxon). Values are means ± SEM. Significance was set at p < 0.05. 243 
244 
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Results 245 
 246 
1-Castration reduces both absolute maximal force and power gains in male mice 247 
 248 
We measured the absolute maximal force of the TA muscle in response to nerve 249 
stimulation, an important aspect of muscle performance, in male mice. Castration performed 250 
at 1 month of age reduced the gain in absolute maximal force between 1 month and 6 251 
months. Indeed, absolute maximal force was decreased in 3- and 6-month old male castrated 252 
mice (-18% and -17% respectively), as compared to age-matched intact male mice (p< 253 
0.05)(Figure 1A). The absolute maximal force was related to the specific maximal force 254 
(absolute maximal force/muscle weight), and the muscle weight (see below). We found that 255 
the increase in specific maximal force between 1 month and 6 months was reduced by 256 
castration. Specifically, specific maximal force was reduced in castrated male mice at 6 257 
months of age, as compared to age-matched intact male mice (Figure 1B)(p <0.05).  258 
 259 
Absolute maximal power, another important aspect of TA muscle performance, was also 260 
measured. The gain in absolute maximal power between 1 month and 3 or 6 months 261 
observed in intact male mice was reduced by castration. Absolute maximal power was 262 
decreased by 30% and 18% in 3- and 6-month old castrated male mice, respectively (p < 263 
0.05), as compared to age-matched male intact mice (Figure 1C). Absolute maximal power 264 
was related to specific maximal power, and muscle weight (see below). We found that 265 
specific maximal power was reduced in 3- and 6 month old castrated male mice, as 266 
compared to age-matched male intact mice (Figure 1D)(p < 0.05).  267 
 268 
We also measured TA muscle weight, because absolute maximal force and power are 269 
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proportional to muscle size (muscle cross-section area and volume/weight). The gain in 270 
muscle weight observed between 1 month and 3 months in intact male mice was reduced by 271 
castration in male mice. Muscle weight was decreased by -16% in male castrated mice at 3 272 
months of age (p <0.05), as compared to age-matched male intact mice (Figure 1E). 273 
However, at 6 months of age, muscle weight was similar in castrated and age-matched intact 274 
male mice (Figure 1E).  275 
 276 
Together, our results indicate that castration before puberty decreases the gains in absolute 277 
maximal force and power between 1 month and 6 months of TA muscle in male mice. This 278 
is due to reduced gain in specific maximal force and power, i.e. two keys aspects of muscle 279 
contractile quality, and a delayed muscle growth (increase in muscle weight) in male mice. 280 
 281 
2-Castration decreases absolute maximal force gain in female mice 282 
 283 
Castration reduced the gain in TA absolute maximal force between 1 month and 3 or 6 284 
months in female mice such that values were decreased in 3- and 6-month old female 285 
castrated mice by -17% and -11% respectively, as compared to age-matched female intact 286 
mice (p< 0.05)(Figure 1F). Moreover, the gain in specific maximal force between 1 month 287 
and 6 months was reduced by castration since specific maximal force was lower in castrated 288 
female mice, at 3 and 6 months of age, as compared to age-matched intact female mice 289 
(Figure 1G)(p < 0.05).  290 
 291 
Castration did not affect the gain in TA absolute maximal power between 1 month and 3 or 292 
6 months in female mice. Indeed, absolute maximal power was not different in 3- and 6-293 
month old female between castrated and intact mice (Figure 1H). Similarly, castration did 294 
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not affect specific maximal power since specific maximal power did not significantly 295 
increase in 3- and 6 month old castrated female mice, as compared to age-matched female 296 
intact mice (p=0.07)(Figure 1I).  297 
 298 
Castration reduced the gain in TA muscle weight between 1 month and 3 or 6 months in 299 
female mice. Indeed, female castrated mice demonstrated a reduction of 11 and 5% in 300 
muscle weight at 3 and 6 months of age, respectively, as compared to age-matched intact 301 
female mice (Figure 1J)(p <0.05).  302 
 303 
Taken together, our results indicate that castration before puberty decreases absolute 304 
maximal force of TA muscle in female mice, but not absolute maximal power. The reduced 305 
absolute maximal force results from the decrease of both specific maximal force, i.e. an 306 
aspect of muscle quality, and muscle weight. 307 
 308 
3- Castration reduces sexual dimorphism regarding muscle performance 309 
 310 
Sexual dimorphism was studied in both intact and castrated mice. We found first a sexual 311 
dimorphism concerning absolute maximal force of TA muscle in intact mice. The absolute 312 
maximal force of female intact mice was reduced (-10%) as compared to male intact mice 313 
(compare Figure 1F to Figure 1A)(p <0.05). Secondly, in contrast, absolute maximal force 314 
of female and male castrated mice did not differ (compare Figure 1F to Figure 1A). 315 
Moreover, there was no sexual dimorphism regarding specific maximal force in intact and 316 
castrated mice. Indeed, specific maximal force of intact and castrated female mice were 317 
similar as compared to intact and castrated age-matched male mice (compare Figure 1G to 318 
Figure 1B).  319 
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 320 
Absolute maximal power of the TA muscle also differed between sexes in intact mice. 321 
Absolute maximal power of intact female mice was decreased (-18%), as compared to intact 322 
age-matched male mice (compare Figure 1H to Figure 1C)(p <0.05). In contrast, the 323 
absolute power of 3-month old female castrated mice was increased as compared to age-324 
matched male castrated mice (compare Figure 1H to Figure 1C)(p < 0.05). We also found a 325 
sexual dimorphism concerning specific maximal power, since female intact mice had a 326 
lower specific maximal power, as compared to age-matched male intact mice (compare 327 
Figure 1I to Figure 1D). In contrast, the specific maximal power of female castrated mice 328 
was increased, as compared to age-matched male castrated mice (compare Figure 1I to 329 
Figure 1D)(p <0.05). 330 
 331 
Finally, there was a sexual dimorphism concerning TA muscle weight in intact mice. 332 
Muscle weight of 3- and 6- month old female intact mice was reduced (-6%), as compared to 333 
age-matched male intact mice (compare Figure 1J to Figure 1E)(p <0.05). Similarly, the 334 
muscle weight of 6-month old castrated female castrated mice, but not 3-month old castrated 335 
female mice, was decreased as compared to age-matched male castrated mice (compare 336 
Figure 1J to Figure 1E)(p<0.05). 337 
 338 
Together, these results indicate that in intact mice there is a sexual dimorphism concerning 339 
both absolute maximal force and power of the TA muscle. The reduced muscle performance 340 
in female mice is due to a decreased specific maximal force and power, i.e muscle quality, 341 
and a lower muscle weight. Moreover, castration in both sexes reduces the sexual 342 
dimorphism regarding absolute maximal force and power. 343 
 344 
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4- Deficiency in muscle fibre AR does not alter the effect of castration on muscle 345 
performance in male mice 346 
 347 
To determine if muscle fibre AR mediates MGRF-induced performance gain, male ARskm-/y 348 
mice, in which muscle fibre AR is selectively ablated, as well as male ARL2/y (control) 349 
littermates, were castrated at 1 month of age, and analyzed at 3 months of age. In agreement 350 
with previous results (9), absolute maximal force of the TA muscle was lower in intact 351 
ARskm-/y mice than in ARL2/y mice (Figure 2A)(p <0.05). Interestingly, we found that 352 
absolute maximal force was similarly decreased in castrated male mice, as compared to 353 
genotype-matched intact male mice, in both genotypes (-29% for ARskm-/y mice and -28% for 354 
ARL2/y mice)(Figure 2A)(p <0.05). Specific maximal force was unchanged by castration in 355 
both genotypes (Figure 2B). Moreover, TA muscle weight was similarly reduced in 356 
castrated male mice (-33% for ARskm-/y mice and -29% for ARL2/y mice), as compared to 357 
genotype-matched intact male mice (Figure 2C)(p <0.05).  358 
 359 
Together our results indicate that muscle fibre AR deficiency does not alter the effect of 360 
castration on TA muscle performance, suggesting that the action of MGRF is not mediated 361 
by muscle fibre AR. 362 
 363 
5-Reduced muscle performance is not related to altered neuromuscular transmission in 3-364 
month old castrated mice 365 
 366 
It has been reported that androgens influence neuromuscular transmission (3). To determine 367 
whether neuromuscular transmission failure contributes to the reduced absolute maximal 368 
force in castrated mice, we also performed electrical stimulation of the TA muscle that can 369 
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directly initiate muscle action potentials, without the need of neuromuscular transmission (8, 370 
16, 51). We found that absolute maximal force in response to nerve stimulation was 371 
decreased by castration in 3-month old mice of both sexes (Figures 3A and B)(p<0.05), 372 
confirming our previous results (Figures 1A and G). Interestingly, direct TA muscle 373 
stimulation with a high strength voltage did not improve absolute maximal force in 3-month 374 
old castrated mice of both sexes since there was no difference between nerve and muscle 375 
stimulations (Figures 3A and B), indicating no neurotransmission failure. 376 
 377 
To complete the analysis of neuromuscular transmission, we checked that castration does 378 
not alter neuromuscular junction morphology in plantaris muscle fibres. Before that, we 379 
confirmed that absolute maximal force and weight of the plantaris muscle were decreased in 380 
3-month-old male castrated mice, as compared to age-matched intact male mice (p< 381 
0.05)(Figure 3C). In contrast, specific maximal force was unchanged by castration (Figure 382 
3C), indicating that the effects of castration on muscle performance were similar in plantaris 383 
and TA muscles, at least in 3-month old male mice. Plantaris muscle fibres isolated from 3-384 
month-old castrated male mice were stained with α-BTX to detect AChR clusters and with a 385 
mixture of antibodies against neurofilament and synaptophysin to label axonal branches and 386 
nerves terminals, respectively. The structure of the synapse in castrated mice was 387 
indistinguishable from intact ones. Indeed, all endplates analyzed formed a continuous 388 
branched postnatal topology and exhibited a typical and «pretzel-like» morphology (Figure 389 
3D). The fact that AChR-rich endplate area per NMJ was reduced by 30% in castrated mice 390 
(p < 0.05)(Figure 3E) could be explained by the decreased fibre size as shown below. 391 
Moreover, both in castrated and intact mice, axonal branches properly innervated the 392 
postsynaptic counterpart and nerve terminals were in perfect registry with AChR clusters. 393 
Quantitative analysis revealed that the synaptophysin area per NMJ (Figure 3F) as well as 394 
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the overlap area between pre- and postsynaptic elements (Figure 3G) were unchanged in 395 
castrated mice compared to intact ones.  396 
 397 
Taken together, these observations demonstrate that castration does not disturb NMJ 398 
structure, in agreement with the observations that 3-month old castrated male mice exhibit 399 
normal neuromuscular transmission, excluding the possibility that reduced performance is 400 
explained by decreased muscle activation.   401 
 402 
6-Reduced muscle performance is related to fibre atrophy and fibrosis in 3-month old 403 
castrated mice 404 
 405 
As mentioned above, part of the reduction in muscle performance is related to decreased 406 
muscle weight in 3-month old castrated mice of both sexes. Therefore, we further analysed 407 
the reduced TA muscle weight in 3-month castrated mice of both sexes (Figure 4A), as 408 
previously shown (Figures 1E and J), and found that it was not associated with a decrease in 409 
bone growth in castrated mice of both sexes. Indeed, the length of the tibia was not changed 410 
by castration in both 3-month old male (17.8 ± 0.3 mm in castrated versus 18.2 ± 0.3 mm in 411 
intact mice) and female (18.0 ± 0.1 mm in castrated versus 18.3 ± 0.2 mm in intact mice) 412 
mice. Moreover, the reduced muscle weight in castrated mice was related to muscle fibre 413 
atrophy since histological analyses revealed a left shift in the fibre diameter distribution in 414 
both 3-month old castrated mice of both sexes (Figures 4BC). In line, there was an increase 415 
in fibrosis in 3-month old castrated mice (14.2±0.9 % in castrated versus 11.7±2.0 % in 416 
intact mice)(p<0.05)(Figure 4D). We also determined whether fibre atrophy was 417 
accompanied by an increase in the percentage of fibres expressing MHC-2a that are fast 418 
fibres having small fibre diameter. We found that the percentage of fibres expressing MHC-419 
2a was not modified by castration in 3-month old mice of both sexes, indicating no change 420 
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in fibre type composition in the muscle (Figure 4E).  421 
 422 
Together, our results indicate that reduced muscle performance gain in 3-month old 423 
castrated mice of both sexes is associated with decreased muscle fibre growth and increased 424 
fibrosis but no change in fibre type composition. 425 
 426 
7-Castration alters intramuscular remodeling pathways in 3-month old male mice 427 
 428 
We first evaluated the activation of bone morphogenetic protein (BMP) signaling via 429 
Smad1/5/9, that is an important emergent pathway controlling muscle size and performance 430 
(61, 72). We investigated whether castration before puberty influences the BMP signaling 431 
axis in skeletal muscle. Castration in 3 month-old male mice altered neither the amount of 432 
phosphorylated Smad1/5/9 (Figures 5A and B), nor activin-like kinase 3 (ALK3) transcript 433 
levels (Figure 5C). Smad4 transcript levels were decreased by castration (Figure 434 
5D)(p<0.05), but those of the downstream factor Id1 (inhibitor of DNA binding) were 435 
unaffected in castrated male mice (Figure 5E). Moreover, castration in 3-month-old female 436 
mice did not alter ALK3 (Figure 5C), Smad4 (Figure 5D), and Id1 (Figure 5E) transcript 437 
levels (p <0.05). Together, these results suggest no major change in Smad1/5/9 signaling 438 
with castration in both 3-month old male and female mice.  439 
 440 
We then determined the effect of castration on the ubiquitin proteasome system that plays 441 
an important role in muscle physiology and atrophic process (4, 44). Castration in 3-month 442 
old male mice decreased the levels of the protein phosphorylated (inactivated) form of 443 
Foxo3a (Figures 6A and B), without changing that of phosphorylated Foxo1 (Figures 6A 444 
and C), two transcription factors important for the regulation of E3 ubiquitin ligases. 445 
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Moreover, we found that the transcript levels of Murf1 (Figure 6D) and FbXO30 (Figure 6E) 446 
were reduced in 3-month old castrated male mice, as compared to age-matched intact male 447 
mice (p< 0.05), whereas that one of atrogin 1 was unchanged (Figure 6F). In contrast, 448 
castration did not affect the transcript levels of Murf1, FbXO30 and atrogin 1 in 3-month-449 
old female mice (Figures 6D-F). Together, these results suggest that 3-month after castration 450 
E3 ubiquitin ligases (atrogin 1, Murf1, and FbXO30) might be less active in males and 451 
unchanged in females.  452 
 453 
In addition, we measured the transcript levels of IGF-1 and MSTN (myostatin), encoding 454 
proteins regulating muscle growth and function (44, 58, 66). In 3-month-old mice, castration 455 
increased the transcript level of MSTN in males, but did not affect it in females (Figure 6G). 456 
In contrast, the transcript level of IGF-1 was unchanged in castrated males and increased in 457 
castrated females (Figure 6H).  458 
 459 
Together, our results indicate that reduced muscle performance gain is associated with 460 
changes in the levels of ubiquitin ligases and MSTN in 3-month old male castrated mice, but 461 
not in Smad1/5/9 signaling. 462 
 463 
 464 
  465 
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Discussion 466 
 467 
MGRF promotes long-term muscle contractile quality 468 
 469 
Our results show that castration initiated before puberty decreased the performance of the 470 
TA muscle in 6-month old male mice. Thus, MGRF, between the age of 1 month and 6 471 
months, contribute to 29% and 38% of absolute maximal force and power gains, 472 
respectively (Table 3). The reduced absolute maximal force and power in 6-month old 473 
castrated male mice is due to a lower specific maximal force and power, but not a decreased 474 
muscle weight (Table 3). Therefore, our results support the original and important notion 475 
that endogenous androgens promote postnatal performance gain in 6-month old male mice 476 
via the improvement/maintenance in muscle contractile quality, i.e. specific maximal force 477 
and power, but not enhanced muscle growth. Concerning muscle growth, it is somewhat 478 
unexpected that the increase in muscle weight is only delayed by castration, nuancing the 479 
widespread view that androgens have an overall anabolising effect. Since in the present 480 
study we studied a fast-twitch muscle, it remains to be determined whether the contractile 481 
quality of a muscle with mixed fibre type composition (such as soleus muscle) is similarly 482 
reduced by removal of MGRF in 6-month-old male mice. MSTN encoding myostatin can 483 
also improve muscle contractile quality during postnatal development, but together with an 484 
inhibition of muscle growth (45, 52, 62, 65).  485 
 486 
Our results indicate that increased fibrosis, but not neuromuscular transmission failure, can 487 
explain in part, the reduced specific maximal force and power in 6-month old castrated male 488 
mice. It is possible that the decrease in muscle quality is due to accumulation of 489 
nonfunctional proteins since we found that ubiquitin ligases are presumably less active in 3-490 
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month old castrated male mice. It has been reported that decreased specific maximal force 491 
and power are associated with reduced levels of ubiquitin ligases (44). Our results does not 492 
however, relate to fibre type transition since we found no notable increase in the percentage 493 
of less powerful fibre expressing MHC-2a (20), at least in 3-month old castrated male mice. 494 
These data are in line with previous studies analyzing hypogonadal male mice (63). Finally, 495 
decreased phosphorylation of the myosin light chains could also contribute to the reduced 496 
specific maximal force, since it has been reported that acute androgen (dihydrotestosterone) 497 
administration increases both specific maximal force and phosphorylation of the myosin 498 
light chains (29).  499 
 500 
MGFR are not the only factors involved in muscle performance gain 501 
 502 
A finding of interest is that the contribution of MGRF to muscle performance gain is not 503 
predominant (Table 3) since 62 to 71% of the muscle performance gains between 1 and 6 504 
months are due to other factors. Other endocrine factors affecting muscle quality during 505 
muscle development may be considered. Thyroid hormones alter fibre transition that occurs 506 
during postnatal development (1, 26), and potentially affect specific maximal power since 507 
fast type fibres are more powerful than slow type fibres. In mice expressing dominant 508 
negative mutant IGF-1 receptors in skeletal muscle, there is a prevalence of fast fibres (68), 509 
suggesting a possible effect of endocrine or local IGF-1 on specific maximal power. 510 
However, we found that IGF-1 transcript levels were not modified in male castrated mice, at 511 
least at the age of 3 months. Concerning growth hormone, its direct effect on muscle is 512 
unlikely since muscle growth hormone receptor deficiency does not affect fibre type 513 
composition in postnatal muscle (70) and it has been reported that growth hormone does not 514 
alters specific maximal force (10).  515 
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 516 
The effects of MGRF on muscle performance and growth are not mediated by fibre AR and 517 
BMP signaling through Smad1/5/9 phosphorylation in 3-month old male mice 518 
 519 
Interestingly, the effect of castration before puberty on absolute maximal force gain is not 520 
abolished in the absence of muscle fibre AR, at least in 3-month old male mice. At the age 521 
of 3 months, the reduced absolute maximal force in castrated male mice resulted from a 522 
lower muscle weight and fibre atrophy. These results suggest that the action of endogenous 523 
androgens on muscle performance gain and growth is not mediated by muscle fibre AR, at 524 
least in 3-month old male mice. These findings extend those of a previous study showing 525 
that 1 month-castration performed in the adult stage similarly decreased muscle weight in 526 
deficient or non-deficient muscle fibre AR male mice (9). In accordance, it has been 527 
reported that the postnatal development of hindlimb muscle is independent from fibre AR 528 
signaling in mice (9, 13, 55).  529 
 530 
Many other cells express AR, in particular satellite cells. However, in the present study, the 531 
possibility that androgen effect on muscle weight is mediated via the AR of satellite cells is 532 
unlikely since satellite cells do not contribute to muscle growth after the age of 3 weeks. 533 
Indeed, there is no further myonuclei addition at this postnatal stage in mice (71). A 534 
possibility is that androgen effect on muscle growth can be mediated via AR localized in the 535 
brain. This hypothesis is supported by the facts that: (i) the level of voluntary exercise in 536 
male animals is negatively and positively modulated by castration and androgen 537 
administration, respectively (14, 35) and (ii) reduced activity alters muscle performance and 538 
size (31).  539 
 540 
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Another possibility is that other endocrine/paracrine factors mediate the effect of androgens 541 
on muscle weight. Indeed, testosterone can be converted to estrogens by aromatase, and 542 
estrogens are known to affect muscle physiology (FGRF, see below). GH and IGF-1 are 543 
unlikely since it has been reported that the circulating GH and IGF-1 are not mandatory for 544 
mediating the effect of androgens, at least in highly androgen responsible muscle from adult 545 
male mice (64). Several recent studies reported that androgens interact with MSTN, a 546 
member of the transforming growth factor-beta (TGFβ) superfamily, in skeletal muscle (5, 547 
12, 46, 65). In line, we found that the transcript level of MSTN was increased by castration 548 
in 3-month-old male mice. Since inactivation of MSTN increases muscle growth (62, 66), 549 
the higher expression of MSTN in castrated male mice can explain muscle atrophy.  550 
 551 
Another member of the (TGFβ) superfamily, BMP signaling through Smad1/5/9 552 
phosphorylation is an emergent pathway controlling muscle size (61, 72). Indeed, it has been 553 
suggested that BMP signaling participates in postnatal muscle development, since the 554 
phosphorylation of Smad1/5/9 is lower in 6-month old (adult) mice as compared to younger 555 
mice (72). BMPs are proteins that bind to BMP receptor, such as ALK3, that in turn 556 
phosphorylates Smad1/5/9 proteins, promoting with Smad4, the regulation of target genes, 557 
in particular Id1 and various processes regulating muscle size (60). However, our data 558 
provide initial insights that the delayed muscle growth in 3-month old castrated mice is not 559 
likely to be related to changes in BMP signaling through Smad1/5/9 phosphorylation. The 560 
ubiquitin proteasome system also plays an important role in the atrophic process (4). 561 
However, in contrast to increased MSTN expression, the likely less active ubiquitin ligases 562 
cannot explain the reduced weight in 3-month old castrated male mice. 563 
 564 
Differential effect of FGRF versus MGFR on muscle performance gain 565 
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 566 
Another novel finding of our study is that, in contrast to MGRF in male mice, FGRF does 567 
not contribute to maximal power gain between 1 month and 6 months in female mice 568 
(Table 3). However FGRF contribute to 20% of maximal force gain in 6-month old 569 
female mice (Table 3), similarly to MGFR in male mice, and its action is irrespective of any 570 
change in neurotransmission. These results differ, for yet unknown reasons, from those of 571 
previous studies showing that castration increases or has no effect on absolute maximal 572 
force in growing female rats (42, 67). In line with our results, it has been shown that 573 
estrogens positively modulate absolute maximal force in adult female mice (24, 49, 50). 574 
Indeed, castration reduces specific maximal force and maximal calcium activated force of 575 
permeabilized fibres in adult female mice, and this effect is explained by a lower fraction of 576 
myosin heads strongly bound to actin (49, 50).  577 
 578 
Together with the reduced specific maximal force, i.e muscle quality, a lower muscle weight 579 
explains the effect of castration on the absolute maximal force in 3- and 6-month old female 580 
mice. Thus, in contrast to MGRF, we found that FGRF also contributes to the increase in 581 
muscle weight during postnatal development, even though its contribution is rather small 582 
(12%)(Table 3). Our results also demonstrate that FGRF promotes the growth of muscle 583 
fibres, in agreement with a recent study (39). However, this fibre growth is not related to 584 
changes in MSTN, BMP signaling through Smad1/5/9 phosphorylation and ubiquitin 585 
ligases, at least in 3-month old female mice. The increased transcript level of IGF-1, a factor 586 
promoting muscle growth, in 3-month old castrated female mice could be a compensatory 587 
phenomenon. It is possible that impaired intrinsic function of satellite cells (39) contributes 588 
to the reduced muscle growth observed after castration in female mice.  589 
 590 
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It also remains to be confirmed whether the action of putative endogenous estrogens on 591 
absolute maximal force is mediated via estrogen receptor (ER) that exhibits different 592 
subtypes, ERα, ERβ and Gper. It was reported that estrogen effects on muscle are mediated 593 
in part via muscle ERα in mice (6, 54). In accordance, ERβ deficiency does not lead to 594 
significant change in absolute maximal force (23). However, a recent study demonstrated 595 
that estrogens have a rapid effect on muscle contractility via both ERβ and Gper (40), e.g., 596 
the potentiated force was increased. There is a possibility that estrogen effects can be 597 
mediated by brain ER since estrogens increase the level of voluntary exercise (14, 21) which 598 
is known to modulate muscle performance and growth. In agreement, a recent study 599 
suggests that castration-induced muscle atrophy could result from the reduced level of motor 600 
activity in adult female mice (21). However, it has been reported that the benefits of 601 
estrogens is independent of physical activity, e.g. can be observed in inactive muscle (24). In 602 
summary, we demonstrate that FGRF play a role in maximal force gain and muscle mass 603 
development, contrasting the traditional view that estrogens have no impact on muscle 604 
postnatal development. The signaling axis through which these effects are mediated is still 605 
not well defined. 606 
 607 
Sexual dimorphism concerning muscle performance is reduced by castration 608 
 609 
We also report several differences between sexes concerning muscle performance at 6 610 
months of age, in intact mice. The reduced absolute maximal force in 6-month intact female 611 
mice, as compared to males,  is explained by a lower muscle weight, in line with previous 612 
studies, without difference in specific maximal force (62). Our results suggest that the lower 613 
muscle weight in female mice is related to sex-based difference in IGF-1 gene expression 614 
(lower transcript level in female) but not BMP signaling, ubiquitin ligases and MSTN gene 615 
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expression. Regarding absolute maximal power, we found that the lowered absolute 616 
maximal power in 6-month old female intact mice results from both reductions in specific 617 
maximal power and muscle weight, as previously shown (62). We report here that reduced 618 
specific maximal power is not related to an increased percentage of less powerful fibres 619 
expressing MHC-2a. It is possible that the increased fibrosis in female mice contributes, at 620 
least in part, to the reduced specific maximal power.  621 
 622 
Another novel finding of our study is that castration before puberty reduces the sexual 623 
dimorphism concerning both absolute maximal force and power in 6-month old mice, 624 
indicating that MGRF and FGRF contribute to the sex-based differences regarding muscle 625 
performance. Concerning the lower muscle weight that explains the lower absolute 626 
maximal force and power in intact female mice, we found that castration does not fully 627 
eliminate this sex-based difference, suggesting that both endogenous sexual hormones and 628 
other additional factors can contribute to this aspect, such as MSTN (43) or IGF-1. In line, 629 
we found a sex-based difference in MSTN mRNA level in castrated mice. The lower 630 
specific maximal power in intact female mice is reversed by castration (increased specific 631 
maximal power in castrated females versus castrated males), suggesting that MGRF and 632 
FGRF have beneficial and detrimental actions on specific maximal power, respectively. Our 633 
results indicate that these effects cannot be attributed to a sex-based difference in fibre type 634 
specification in castrated mice, a finding that adds to an equivocal body of evidence 635 
regarding the respective effects of androgens and estrogens on muscle fibre type 636 
specification (2, 27, 39, 53, 56, 63).  637 
 638 
Conclusion 639 
 640 
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In summary, our study indicates that MGFR promotes muscle absolute maximal force and 641 
power gains between 1 month and 6 months in male mice, mainly via promoting muscle 642 
contractile quality, and without affecting neuromuscular transmission. In 3-month old male 643 
mice, the effects of MGRF on muscle performance are not mediated by muscle fibre AR. In 644 
female mice, FGRF promotes absolute maximal force gain between 1 month and 6 months 645 
but not absolute maximal power gain. Here we provide preliminary insights that demonstrate 646 
that the effects of MGRF and FGRF in 3-month old mice are not related to alterations in 647 
BMP signaling through Smad1/5/9. However, our results suggest that the action of MGRF 648 
could be mediated via the upregulation of ubiquitin ligases in 3-month old male mice. Now, 649 
more protracted efforts are needed to define the signaling cascades responsible for the 650 
effects of sex-related hormones. We also show that MGRF and FGRF only marginally 651 
contribute to muscle performance gain between 1 month and 6 months of age in both sexes, 652 
indicating the existence of additional factors, endocrine or not. Finally, we have 653 
demonstrated that MGRF and FGRF contribute to the sexual dimorphism regarding muscle 654 
performance in adult mice. Thus, we provide evidence demonstrating that both MGRF and 655 
FGRF are required for the normal postnatal development of muscle performance in mice of 656 
both sexes. 657 
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Legends of figures 920 
 921 
Figure 1. Muscle performance in castrated male and female mice (TA muscle).  922 
A: Absolute maximal force in male mice. B: Specific maximal force in male mice. C: 923 
Absolute maximal power in male mice. D: Specific maximal power in male mice. E: Muscle 924 
weight in male mice. F: Absolute maximal force in female mice. G: Specific maximal force 925 
in female mice. H: Absolute maximal power in female mice. I: Specific maximal power in 926 
female mice. J: Muscle weight in female mice. 927 
1m : 1-month old ; 1.5 : 1.5-month old ; 3m : 3-month old; 6m : 6-month old ; cas : 928 
castrated. 929 
c : Castrated mice different from corresponding intact mice (p < 0.05).  930 
s : Female mice different from corresponding male mice (p <0.05). 931 
n=8-16/group; 932 
The data in the figure were collected during the first set of measurements, in the same mice. 933 
 934 
Figure 2. Muscle performance in 3-month old castrated male mice with deficiency in muscle 935 
fibre AR (TA muscle).  936 
A: Absolute maximal force. B:  Specific maximal force. C: Muscle weight. 937 
ARL2/y : Wild-type mice. ARskm/-y :  Mice with muscle fibre AR deficiency. 938 
c : Castrated mice different from corresponding intact mice (p < 0.05).  939 
n=6-8/group 940 
The data in the figure were collected during the second set of measurements, in the same 941 
mice. 942 
 943 
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Figure 3. Neuromuscular transmission and neuromuscular junction morphology in 3-month 945 
old castrated mice. 946 
A: Absolute maximal force in response to nerve or muscle stimulation in male mice (TA 947 
muscle). B: Absolute maximal force in response to nerve or muscle stimulation in female 948 
mice (TA muscle). C: Absolute and specific maximal forces and weight of plantaris muscle 949 
(male mice). D: Representative images of neuromuscular junction in castrated male mice 950 
(plantaris muscle). Scale bar = 20 μm. E: AChR-rich endplate area (plantaris muscle, male 951 
mice). F: pre/post overlap (plantaris muscle, male mice). G: Synaptophysin area (plantaris 952 
muscle, male mice).  953 
c : Castrated mice different from corresponding intact mice (p < 0.05).  954 
n=9-14/group for A-C; n=20/group for D-G. 955 
The data in the figure were collected during the third set of measurements, in the same mice. 956 
 957 
 958 
Figure 4: Muscle and fibre atrophy, and fibre type composition in 3-month old male and 959 
female castrated mice (TA muscle). 960 
A: Muscle weight. B: Distribution of diameter (min ferret) of fibres in castrated male mice, 961 
using histological analysis. C: Distribution of diameter (min ferret) of fibres in castrated 962 
female mice. D: Fibrosis using histological red Sirius staining. E: Percentage of fibres 963 
expressing MHC-2a, using immunohistological staining.  964 
c : Castrated mice different from corresponding intact mice (p < 0.05).  965 
s : Female mice different from corresponding male mice (p <0.05). 966 
n=10-14 per group for A; n=3-4 per group for B-E. 967 
The data in the figure were collected during the third set of measurements, in the same mice. 968 
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Figure 5. Intramuscular remodeling pathway: markers of BMP signaling through Smad1/5/9 970 
in 3-month old castrated male and female mice (TA muscle).  971 
A : Representative images of Western blots (male mice). B : Protein levels of 972 
phosphorylated Smad1/5/9 (male mice). C: mRNA levels of ALK3. D: mRNA levels of 973 
Smad4. E: mRNA levels of ID1.  974 
Int : intact ; Cas : castrated. 975 
c : Castrated mice different from corresponding intact mice (p < 0.05).  976 
s : Female mice different from corresponding male mice (p <0.05). 977 
n=5-7 per group. 978 
The data in the figure were collected during the third set of measurements, in the same mice. 979 
 980 
Figure 6. Intramuscular remodeling pathway: markers of the ubiquitin proteasome system, 981 
and IGF-1 and MSTN transcript levels in 3-month old castrated male and female mice (TA 982 
muscle).  983 
A : Representative images of blots (male mice). B : Protein levels of phosphorylated Foxo3a 984 
(male mice). C : Protein level of phosphorylated Foxo1 (male mice). D: mRNA levels of 985 
Murf1. E : mRNA levels of FbXO30. F : mRNA levels of atrogin 1. G : mRNA levels of 986 
MSTN. H: mRNA levels of IGF-1.  987 
Int : intact ; Cas : castrated ; IGF-1 : insulin growth factor 1 ; MSTN : myostatin. 988 
c : Castrated mice different from corresponding intact mice (p < 0.05).  989 
s : Female mice different from corresponding male mice (p <0.05). 990 
 n=5-7/group. 991 
The data in the figure were collected during the third set of measurements, in the same mice. 992 
 993 
  994 
 40
Table 1. Body weights. 995 
----------------------------------------------------------------------------------------------------  996 
      Castrated    Intact   997 
----------------------------------------------------------------------------------------------------  998 
3-month old 999 
Male     23.5±0.8c    27.8±0.1   1000 
Female     23.2±0.5     22.9±0.4   1001 
 1002 
6-month-old 1003 
Male     30.9±1.1     30.0±0.6   1004 
Female     30.4±1.5c    25.4±0.8  1005 
---------------------------------------------------------------------------------------------------- 1006 
c : significantly different from intact (p < 0.05).  1007 
n=5-11/group 1008 
The data in the Table 1 were collected during the first set of measurements. 1009 
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Table 2. Primers used. 1012 
------------------------------------------------------------------------------------- 1013 
Name   Sequence 1014 
------------------------------------------------------------------------------------- 1015 
18S   5'-TCGTCTTCGAAACTCCGACT-3' 1016 
   5'-CGCGGTTCTATTTTGTTGGT-3' 1017 
ID1   5'-CTCGGAGTCTGAAGTCGGGA-3' 1018 
   5'-GAACACATGCCGCCTCGG-3' 1019 
ALK3  5'-CTCTGAGAATTCTGAAGAAAGCAGC-3'  1020 
   5'-TCCTGCTGTCTCACTGGTGT-3' 1021 
Smad4  5'-GAATAGCTCCAGCCATCAGTCT-3' 1022 
   5'-GAATGCACAATCGCCGGAGG-3'  1023 
IGF   5'-AGCAGCCTTCCAACTCAATTAT-3' 1024 
   5'-GAAGACGACATGATGTGTATCTTTATC-3'  1025 
MuRF  5'-TGAGGTGCCTACTTGCTCCT-3' 1026 
   5'-GTGGACTTTTCCAGCTGCTC-3' 1027 
MSTN  5'-GCTACCACGGAAACAATCAT-3' 1028 
   5'-CAATACTCTGCCAAATACCA-3' 1029 
Atrogin  5'-TCACAGCTCACATCCCTGAG-3' 1030 
   5'-TCAGCCTCTGCATGATGTTC-3' 1031 
FbxO30s  5'-AGGGACGTTTGTGGCAGTTT-3' 1032 
   5'-ACTGAATCGCCATACCTTCTC-3' 1033 
------------------------------------------------------------------------------------- 1034 
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Table 3. Contribution of male (MGRF) and female (FGRF) gonad-related factors to TA muscle 1037 
performance gains and growth (increased weight) between 1 month and 3 or 6 months of age. 1038 
-------------------------------------------------------------------------------------------------------------- 1039 
     Sex  Age   Force   Power  Weight  1040 
-------------------------------------------------------------------------------------------------------------- 1041 
Contribution of MGRF   1042 
     Male 3 month  26%  58%  31%    1043 
     Male 6 month  29%  38%  0% 1044 
Contribution of FGRF   1045 
     Female 3 month  32%  0%   23%    1046 
     Female 6 month  20%  0%   12% 1047 
---------------------------------------------------------------------------------------------------------------- 1048 
 Force: absolute maximal force; Power: absolute maximal power. The contribution of 1049 
MGRF and FGRF to muscle performance gain was calculated as follow. For example, 1050 
absolute maximal force gain in castrated and intact 6-month old male mice was 142.2% and 1051 
101.3% respectively. Therefore, the contribution of MGF (%) to muscle P0 gain in 6-month 1052 
old male mice was =100-(101.3/142.2)*100) = 28.8%. 1053 
The data in the Table 3 were collected during the first set of measurements. 1054 
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